🇺🇸 FDA
Pipeline program

Stem cells

Cx611-0101

Phase 2 gene_therapy completed

Quick answer

Stem cells for Rheumatoid Arthritis Aggravated is a Phase 2 program (gene_therapy) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Rheumatoid Arthritis Aggravated
Phase
Phase 2
Modality
gene_therapy
Status
completed

Clinical trials